evertex fabrinology limited reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 166.28 million compared to TWD 155.97 million a year ago. Revenue was TWD 226.37 million compared to TWD 243.55 million a year ago. Net income was TWD 12.61 million compared to TWD 12.75 million a year ago. Basic earnings per share from continuing operations was TWD 0.15 compared to TWD 0.15 a year ago. Diluted earnings per share from continuing operations was TWD 0.15 compared to TWD 0.15 a year ago.
For the nine months, sales was TWD 548.89 million compared to TWD 422.6 million a year ago. Revenue was TWD 735.6 million compared to TWD 679.78 million a year ago. Net income was TWD 33.43 million compared to TWD 48.68 million a year ago. Basic earnings per share from continuing operations was TWD 0.39 compared to TWD 0.57 a year ago. Diluted earnings per share from continuing operations was TWD 0.39 compared to TWD 0.57 a year ago.